US drug regulator clears Hugo robot for general surgery, Medtronic says

The company announced the expanded US clearance on 17 November 2026, allowing the system to assist with abdominal operations beyond its earlier urology uses.
In this article
Medtronic, a medical technology company, said the US Food and Drug Administration had cleared its Hugo robotic-assisted surgery system for general surgery procedures. The company estimates that the newly covered procedures account for about 3.5 million US operations a year, using any technology.
The expansion follows Hugo’s initial US clearance in December 2025 for minimally invasive urologic surgery, including removal of the prostate, kidney or bladder. The new clearance extends its use beyond urology.
Which operations are covered?
Medtronic says the clearance covers all upper-abdominal general surgery procedures. Examples include gallbladder removal, small-bowel resection—the removal of all or part of the small intestine—and Roux-en-Y gastric bypass, which creates a small stomach pouch and connects it to a rerouted part of the small intestine. It also covers ventral hernia repair.
The specified lower-abdominal procedures are inguinal hernia repair and appendectomy, or removal of the appendix. A hernia occurs when tissue pushes through a weak spot in surrounding muscle or connective tissue; an inguinal hernia is in the groin. Open repair can use stitches or synthetic mesh.
Hugo has separate movable robotic-arm carts. Surgical teams select and position the arms for the operation and patient, while the surgeon operates from an open console. Rajit Kamal, Medtronic’s general manager of robotic surgical technologies, told The Robot Report that the design helps teams reach surgical sites and position entry points during operations involving several parts of the abdomen.
Medtronic’s current safety information limits Hugo to use on adults by trained physicians in an operating room. The labeling lists potential adverse events including bleeding, infection, burns and perforation of the bowel or a blood vessel.
According to the labeling, the evaluation assessed Hugo as a tool for controlling surgical instruments, not cancer-treatment outcomes or treatment of a particular underlying disease.
Evidence and the next application
Kamal said Medtronic used a US clinical trial and data from outside the US to pursue the general-surgery clearance. Earlier steps included:
- 2022: Hugo received European CE marking for general surgery, providing clinical data for the US submission.
- September 2025: Medtronic said a US hernia-repair study had met its safety and effectiveness endpoints.
- 3 June 2026: Medtronic announced separate US 510(k) filings for general-surgery and gynecologic uses.
Medtronic announced the separate gynecologic filing on 3 June 2026. Medtronic said its prospective Embrace Gynecology study had completed enrollment, with 70 patients at 5 US hospitals. The study evaluates Hugo’s safety and effectiveness in procedures including radical, modified radical and total hysterectomies, which remove the uterus to varying extents, including in patients treated for cancer.
Follow AveNews
Earlier in Technology
SoftwarePHP development team releases PHP 8.6 with safer session defaults
Strict mode and HttpOnly switch from off to on, while SameSite changes from unset to Lax. Existing settings can override the changes, so administrators need to check their configurations after upgrading.
4 min
Physics, Maths & DiscoveriesSutherland and others compile Alpöge’s proposed Riemann proof
Further checks matched five theorem statements and found only standard starting assumptions, but mathematical review of the argument continues.
3 min
SoftwareHackers breach US farmer-payment system, former officials say
The Agriculture Department notified employees, while two former officials warned that the compromised system could provide a route to other sensitive information.
2 min
Sources
Show all 10 sourcesShow fewer
- news.medtronic.comMedtronic announces FDA clearance of general surgery procedures for the Hugo™ robotic-assisted surgery (RAS) system - Nov 17, 2026 (opens in a new tab)
- mugglehead.comMedtronic gets FDA clearance for Hugo general surgery | Mugglehead (opens in a new tab)
- news.medtronic.comMedtronic announces FDA clearance of Hugo™ robotic-assisted surgery system for urologic surgical procedures - Dec 3, 2025 (opens in a new tab)
- grokipedia.comGastric bypass surgery (opens in a new tab)
- grokipedia.comBowel resection (opens in a new tab)
- grokipedia.comHernia (opens in a new tab)
- grokipedia.comInguinal hernia (opens in a new tab)
- grokipedia.comAppendectomy (opens in a new tab)
- The Robot ReportMedtronic’s Hugo surgical robot ready for bigger operation (opens in a new tab)
- news.medtronic.comMedtronic submits 510(k) filings to expand Hugo™ robotic-assisted surgery system into general and gynecologic specialties in the United States - Jun 3, 2026 (opens in a new tab)
